These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8436104)

  • 41. Decreased cisplatin uptake by resistant L1210 leukemia cells.
    Hromas RA; North JA; Burns CP
    Cancer Lett; 1987 Aug; 36(2):197-201. PubMed ID: 3621151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of N-nitrosourea-induced changes in the nucleoid structure and activity of repair enzymes in the development of drug resistance in mice with leukemia L1210].
    Durdyeva ED; Ponomarenko NA; Kukushkina GV; Gorbacheva LB
    Biokhimiia; 1987 Aug; 52(8):1335-43. PubMed ID: 3663767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of altered tyrosine phosphorylation with methotrexate resistance in a cisplatin-resistant subline of L1210 cells.
    Bhushan A; Wroblewski D; Xuan Y; Tritton TR; Hacker MP
    Biochem Pharmacol; 1996 Feb; 51(4):477-82. PubMed ID: 8619893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
    Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
    Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments.
    Canitrot Y; Frit P; Salles B
    Biochem Biophys Res Commun; 1997 May; 234(3):573-7. PubMed ID: 9175754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.
    Ali-Osman F; Berger MS; Rairkar A; Stein DE
    J Cell Biochem; 1994 Jan; 54(1):11-9. PubMed ID: 8126081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells.
    Chao CC
    Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
    Calsou P; Frit P; Salles B
    Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
    Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Nicolson MC; Orr RM; O'Neill CF; Harrap KR
    Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).
    Eastman A; Schulte N
    Biochemistry; 1988 Jun; 27(13):4730-4. PubMed ID: 3167012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of DNA synthesis in different tissues of L1210-leukemia-bearing mice by new platinum (II) complexes.
    Gorneva GA; Grancharov KC; Spassovska NC
    Chemotherapy; 1993; 39(1):63-9. PubMed ID: 8444064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R; Grabowski D; Sweatman TW; Seshadri R; Israel M
    Br J Cancer; 1989 Dec; 60(6):819-26. PubMed ID: 2605093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
    Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
    Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
    Chen G; Zeller WJ
    Cancer Lett; 1992 Oct; 67(1):27-33. PubMed ID: 1423242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The expression of GST pi mRNA in the P388/ADR and L1210/DDP resistant lines examined by synthetic probe].
    Liu YB
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):264-7. PubMed ID: 8174463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
    Eastman A; Illenye S
    Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.